Janssen Global Services Overview

  • Year Founded
  • 1953

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 31,276

Employees

  • Latest Deal Type
  • 2ndary - Private

Janssen Global Services General Information

Description

Manufacturer of pharmaceutical products intended to improve the health of individuals living with serious conditions. The company engages in the research, development, manufacturing, and marketing of pharmaceutical products for a wide range of human medical disorders, including mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies, and cancer, enabling customers to fight sickness with science, improving access with ingenuity.

Contact Information

Formerly Known As
N.V. Laboratoria Pharmaceutica, Laboratoria Pharmaceutica
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1000 U.S. Route 202 South
  • Raritan, NJ 08869
  • United States
+1 (800)
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Technology Systems
Parent Company
Johnson & Johnson
Vertical(s)
LOHAS & Wellness, Manufacturing, HealthTech, Life Sciences, Oncology
Corporate Office
  • 1000 U.S. Route 202 South
  • Raritan, NJ 08869
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Janssen Global Services Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC Completed Generating Revenue
2. Later Stage VC Completed Generating Revenue
1. Merger/Acquisition 01-Jan-1961 Completed Generating Revenue
To view Janssen Global Services’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Janssen Global Services Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products intended to improve the health of individuals living with serious conditions. Th
Pharmaceuticals
Raritan, NJ
31,276 As of 2023

Orth An Der Donau, Austria
 

Ingelheim Am Rhein, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Janssen Global Services Competitors (27)

One of Janssen Global Services’s 27 competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Manufacturing Austria Corporation Orth An Der Donau, Austria
Boehringer Ingelheim Corporation Ingelheim Am Rhein, Germany
Genentech Formerly VC-backed South San Francisco, CA
Pfizer Pakistan Corporation Karachi, Pakistan
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 27 competitors. Get the full list »

Janssen Global Services Patents

Janssen Global Services Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4478050-A1 Method for quantifying bound acetate in glycoconjugates Pending 12-Jun-2023
US-20240400702-A1 Pharmaceutical compositions comprising a bispecific bcma/cd3 antibody at high concentration Pending 09-May-2023
US-20240358754-A1 Bcma-targeted car-t cell therapy for multiple myeloma Pending 19-Apr-2023
FR-3147947-A1 Bcma-targeted car-t cell therapy for multiple myeloma Pending 19-Apr-2023
FR-3147946-A1 Bcma-targeted car-t cell therapy for multiple myeloma Pending 19-Apr-2023 A61K35/17
To view Janssen Global Services’s complete patent history, request access »

Janssen Global Services Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Janssen Global Services Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ben Franklin Technology Partners of Southeastern Pennsylvania Accelerator/Incubator Minority
NB Capital PE/Buyout Minority
To view Janssen Global Services’s complete investors history, request access »

Janssen Global Services Investments & Acquisitions (18)

Janssen Global Services’s most recent deal was a Seed Round with DEEP (Database Software) for . The deal was made on 23-Feb-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DEEP (Database Software) 23-Feb-2024 Seed Round Other Healthcare Technology Systems
MeiraGTx (Botaretigene Sparoparvovec) 21-Dec-2023 Secondary Transaction - Private Buildings and Property
Yumanity Therapeutics (YTX-7739 and Discovery-stage Neuroscience Product Candidates and Targets) 06-Jun-2022 Corporate Asset Purchase Buildings and Property
Anakuria Therapeutics 02-Feb-2022 Merger/Acquisition Biotechnology
Mirum Pharmaceuticals (Rare Pediatric Disease Priority Review Voucher) 20-Dec-2021 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 18 investments and acquisitions. Get the full list »

Janssen Global Services FAQs

  • When was Janssen Global Services founded?

    Janssen Global Services was founded in 1953.

  • Where is Janssen Global Services headquartered?

    Janssen Global Services is headquartered in Raritan, NJ.

  • What is the size of Janssen Global Services?

    Janssen Global Services has 31,276 total employees.

  • What industry is Janssen Global Services in?

    Janssen Global Services’s primary industry is Pharmaceuticals.

  • Is Janssen Global Services a private or public company?

    Janssen Global Services is a Private company.

  • What is Janssen Global Services’s current revenue?

    The current revenue for Janssen Global Services is .

  • Who are Janssen Global Services’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania and NB Capital have invested in Janssen Global Services.

  • Who are Janssen Global Services’s competitors?

    Pfizer Manufacturing Austria, Boehringer Ingelheim, Genentech, Pfizer Pakistan, and Allogene Therapeutics are some of the 27 competitors of Janssen Global Services.

  • Who acquired Janssen Global Services?

    Janssen Global Services was acquired by Johnson & Johnson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »